Cosciens Biopharma Stock Market Value
| CSCI Stock | 2.72 0.67 32.68% |
| Symbol | COSCIENS |
Is there potential for Biotechnology market expansion? Will COSCIENS introduce new products? Factors like these will boost the valuation of COSCIENS Biopharma. Projected growth potential of COSCIENS fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about COSCIENS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding COSCIENS Biopharma requires distinguishing between market price and book value, where the latter reflects COSCIENS's accounting equity. The concept of intrinsic value - what COSCIENS Biopharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push COSCIENS Biopharma's price substantially above or below its fundamental value.
It's important to distinguish between COSCIENS Biopharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding COSCIENS Biopharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, COSCIENS Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
COSCIENS Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to COSCIENS Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of COSCIENS Biopharma.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in COSCIENS Biopharma on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding COSCIENS Biopharma or generate 0.0% return on investment in COSCIENS Biopharma over 90 days. COSCIENS Biopharma is related to or competes with Biora Therapeutics, CervoMed, and Tvardi Therapeutics. More
COSCIENS Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure COSCIENS Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess COSCIENS Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 15.04 | |||
| Information Ratio | 0.0464 | |||
| Maximum Drawdown | 94.83 | |||
| Value At Risk | (28.04) | |||
| Potential Upside | 32.68 |
COSCIENS Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for COSCIENS Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as COSCIENS Biopharma's standard deviation. In reality, there are many statistical measures that can use COSCIENS Biopharma historical prices to predict the future COSCIENS Biopharma's volatility.| Risk Adjusted Performance | 0.0516 | |||
| Jensen Alpha | 0.672 | |||
| Total Risk Alpha | (0.76) | |||
| Sortino Ratio | 0.0459 | |||
| Treynor Ratio | 0.6313 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of COSCIENS Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
COSCIENS Biopharma February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0516 | |||
| Market Risk Adjusted Performance | 0.6413 | |||
| Mean Deviation | 7.46 | |||
| Semi Deviation | 10.86 | |||
| Downside Deviation | 15.04 | |||
| Coefficient Of Variation | 1900.09 | |||
| Standard Deviation | 14.88 | |||
| Variance | 221.45 | |||
| Information Ratio | 0.0464 | |||
| Jensen Alpha | 0.672 | |||
| Total Risk Alpha | (0.76) | |||
| Sortino Ratio | 0.0459 | |||
| Treynor Ratio | 0.6313 | |||
| Maximum Drawdown | 94.83 | |||
| Value At Risk | (28.04) | |||
| Potential Upside | 32.68 | |||
| Downside Variance | 226.15 | |||
| Semi Variance | 117.94 | |||
| Expected Short fall | (9.77) | |||
| Skewness | 1.24 | |||
| Kurtosis | 5.64 |
COSCIENS Biopharma Backtested Returns
COSCIENS Biopharma appears to be abnormally volatile, given 3 months investment horizon. COSCIENS Biopharma secures Sharpe Ratio (or Efficiency) of 0.0526, which signifies that the company had a 0.0526 % return per unit of volatility over the last 3 months. By analyzing COSCIENS Biopharma's technical indicators, you can evaluate if the expected return of 0.78% is justified by implied risk. Please makes use of COSCIENS Biopharma's risk adjusted performance of 0.0516, and Mean Deviation of 7.46 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, COSCIENS Biopharma holds a performance score of 4. The firm shows a Beta (market volatility) of 1.22, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, COSCIENS Biopharma will likely underperform. Please check COSCIENS Biopharma's semi variance, and the relationship between the maximum drawdown and daily balance of power , to make a quick decision on whether COSCIENS Biopharma's price patterns will revert.
Auto-correlation | -0.18 |
Insignificant reverse predictability
COSCIENS Biopharma has insignificant reverse predictability. Overlapping area represents the amount of predictability between COSCIENS Biopharma time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of COSCIENS Biopharma price movement. The serial correlation of -0.18 indicates that over 18.0% of current COSCIENS Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.18 | |
| Spearman Rank Test | -0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 0.08 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out COSCIENS Biopharma Correlation, COSCIENS Biopharma Volatility and COSCIENS Biopharma Performance module to complement your research on COSCIENS Biopharma. For more detail on how to invest in COSCIENS Stock please use our How to Invest in COSCIENS Biopharma guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
COSCIENS Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.